Last month, Nox Medical launched a three-part webinar series titled “See Everything at Once” where we will look at the state of polysomnography sleep studies and what the future may hold for attended in-laboratory and unattended ambulatory studies.
The second session will feature a conversation with Taiwanese sleep researchers Wan-Ju, Cheng MD, Ph.D., and Hang, Liang Wen MD, Ph.D., about their research on Endo-Phenotyping in sleep. Respiratory Endo-Phenotyping is a methodology for identifying the pathophysiological traits of sleep apnea by better utilizing the wealth of data collected in a polysomnography sleep study. A significant limitation of current sleep diagnostics is that they do not provide information regarding sleep apnea’s underlying cause or impact in different individuals. Endo-Phenotyping could further help to guide combination therapy by identifying which traits to target with drugs or devices.
During the session, Drs. Hang and Wan-Ju will talk about their research on Endo-Phenotyping and share some initial results. They will discuss how endophenotypes of OSA are associated with CPAP treatment adherence and outcomes. Furthermore, the feasibility of using Endo-Phenotyping in clinical practice will be discussed.
Nox Medical has been involved in research studies on Endo-Phenotyping. Endotyping is not available in Nox Medical’s sleep diagnostic devices.
During our second webinar session with Dr. Hang, MD, Ph.D. and Dr. Wan-Ju, MD, Ph.D., titled Endo-Phenotyping in Sleep, many pressing questions will be addressed, including:
- Current state and past studies of Endo-Phenotyping
- Can treatments be optimized based on Endo-Phenotyping of OSA?
- What does phenotyping mean for clinical outcomes?
Hang Liang Wen MD., Ph.D.
Hang, Liang Wen, MD, Ph.D. is a Professor of School of Nursing & Graduate of Nursing at China Medical University, and Chief of Sleep Medicine Center at China Medical University Hospital, Taichung, Taiwan. He is also an attending Physician of Division of Pulmonary and Critical Care at China Medical University Hospital. Dr. Hang received his MD at China Medical University, School of Medicine, and completed his Ph.D. in Social Science, health promotion administration at Asia University in 2013. His current and past research focus and area of expertise include sleep medicine, COPD and Asthma, and Critical and Respiratory Care. Dr. Hang is a former President of the Taiwan Society of Sleep Medicine.
Wan-Ju Cheng MD., Ph.D.
Wan-Ju, MD, Ph.D. is a Director of the Division of Psychiatry at China Medical University Hospital, Taichung, Taiwan, and an Associate Professor at the Department of Public Health at China Medical University. She is also an Assistant Professor at the Department of Public Health at China Medical University, and an attending Psychiatrist at China Medical University Hospital. Dr. Wan-Ju received her MD from the National Yang-Ming University, Taipei, Taiwan. She completed her Ph.D. at the Institute of Health Policy and Management, National Taiwan University. Her current and past research focus and area of expertise include sleep medicine, addiction science, occupational mental health, and gender variance. Dr. Wan-Ju has served as an editorial board member for several journals including the American Journal of Industrial Medicine, International Archives of Occupational and Environmental Health, Science of the Total Environment, Brain Behavior and Immunity Health, and more.
To sign up for the second session of See Everything at Once scheduled for November 17th at 7:30 a.m. ET / 1:30 CET / 8:30 CST, visit webinars.noxmedical.com.